Drug Search Results
More Filters [+]

Digoxin

Alternative Names: digoxin, digoxine, lanoxicaps, lanoxin, digifab, lanoxin pediatric, digibind, digitek, digox
Latest Update: 2024-09-26
Latest Update Note: Clinical Trial Update

Product Description

Digoxin is used to treat heart failure and abnormal heart rhythms (arrhythmias). It helps the heart work better and it helps control your heart rate. (Sourced from: https://medlineplus.gov/druginfo/meds/a682301.html)

Mechanisms of Action: ATPase Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Algeria | Argentina | Australia | Bangladesh | Belgium | Bosnia | Brazil | Bulgaria | Canada | Chile | China | Colombia | Cyprus | Czech | Denmark | Dominican Republic | Egypt | Estonia | Finland | France | Germany | Greece | Hong Kong | Hungary | Iceland | India | Indonesia | Ireland | Israel | Italy | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Mexico | Morocco | Netherlands | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Singapore | Slovakia | Slovenia | South Africa | Spain | Sri Lanka | Sweden | Switzerland | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Boehringer Ingelheim
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Digoxin

Countries in Clinic: Australia, Brazil, Canada, China, France, Germany, Italy, Spain, Sweden, United States

Active Clinical Trial Count: 25

Highest Development Phases

Phase 3: Atrial Fibrillation

Phase 1: Adenocarcinoma|Breast Cancer|Chronic Obstructive Pulmonary Disease|Esophageal Cancer|Gastrointestinal Cancer|Healthy Volunteers|Hepatitis B, Chronic|Influenza, Human|Non-Small-Cell Lung Cancer|Oncology Solid Tumor Unspecified|Oncology Unspecified|Overweight|Pain Unspecified|Prostate Cancer|Type 2 Diabetes

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

MAGNAM

P3

Recruiting

Atrial Fibrillation

2025-10-31

CA127-1027

P1

Not yet recruiting

Oncology Solid Tumor Unspecified

2025-07-31

HDM1002-106

P1

Not yet recruiting

Healthy Volunteers

2025-02-01

INCB54707-110

P1

Recruiting

Healthy Volunteers

2024-11-23

Recent News Events